Does DINUTUXIMAB Cause Neuroblastoma recurrent? 76 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 76 reports of Neuroblastoma recurrent have been filed in association with DINUTUXIMAB (Unituxin). This represents 11.2% of all adverse event reports for DINUTUXIMAB.
76
Reports of Neuroblastoma recurrent with DINUTUXIMAB
11.2%
of all DINUTUXIMAB reports
49
Deaths
11
Hospitalizations
How Dangerous Is Neuroblastoma recurrent From DINUTUXIMAB?
Of the 76 reports, 49 (64.5%) resulted in death, 11 (14.5%) required hospitalization, and 3 (3.9%) were considered life-threatening.
Is Neuroblastoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DINUTUXIMAB. However, 76 reports have been filed with the FAERS database.
What Other Side Effects Does DINUTUXIMAB Cause?
Pyrexia (144)
Off label use (95)
Pain (74)
Abdominal pain (60)
Hypotension (55)
Neuroblastoma (49)
Anaemia (47)
Aspartate aminotransferase increased (46)
Alanine aminotransferase increased (43)
Hypoxia (42)
What Other Drugs Cause Neuroblastoma recurrent?
TEMOZOLOMIDE (28)
IRINOTECAN (27)
CYCLOPHOSPHAMIDE (26)
FILGRASTIM (23)
PEGFILGRASTIM (23)
TECELEUKIN (21)
DEXAMETHASONE (18)
LORLATINIB (18)
METHADONE (18)
CANNABIDIOL (17)
Which DINUTUXIMAB Alternatives Have Lower Neuroblastoma recurrent Risk?
DINUTUXIMAB vs DINUTUXIMAB BETA
DINUTUXIMAB vs DIOSMIN
DINUTUXIMAB vs DIOSMIN\HESPERIDIN
DINUTUXIMAB vs DIOVAN
DINUTUXIMAB vs DIOVAN HCT